Inventor · disambiguated record
Quinton Norman Wessells
Also filed as: WESSELLS QUINTON N · WESSELLS QUINTON NORMAN
5 granted patents·20 pending applications·0 citations·filing 2021–2025
63Inventor score
Files withARBOR BIOTECHNOLOGIES INC25
Top patents by PatentIndex Score
25 records- 0175US11866746B2Compositions comprising a variant Cas12i4 polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Jan 9, 2024·0 cites·20 claims
- 0273US11946045B2Compositions comprising a variant polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Apr 2, 2024·0 cites·23 claims
- 0372US11821012B2Gene editing systems comprising an RNA guide targeting hydroxyacid oxidase 1 (HAO1) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Nov 21, 2023·0 cites·22 claims
- 0468US11939607B2Gene editing systems comprising an RNA guide targeting lactate dehydrogenase a (LDHA) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Mar 26, 2024·0 cites·21 claims
- 0566US12344870B2Compositions comprising a CRISPR nuclease and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Jul 1, 2025·0 cites·20 claims
- 0665US2025127924A1Gene editing systems comprising an rna guide targeting stathmin 2 (stmn2) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 0765US2024254494A1Gene editing systems comprising an rna guide targeting hydroxyacid oxidase 1 (hao1) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 0865US2023032141A1Gene editing systems comprising an rna guide targeting hydroxyacid oxidase 1 (hao1) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 0965US2023203539A1Gene editing systems comprising an rna guide targeting stathmin 2 (stmn2) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1063US2024309346A1Compositions comprising a variant cas12i4 polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1161US2022396782A1Gene editing systems comprising an rna guide targeting transthyretin (ttr) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1261US2024261435A1Gene editing systems comprising an rna guide targeting transthyretin (ttr) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1361US2024141388A1Compositions comprising a variant polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1460US2025290053A1Compositions comprising a crispr nuclease and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2025·Application pending·0 cites
- 1559US2024035010A1Compositions comprising a variant polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2023·Application pending·0 cites
- 1657US2023034581A1Gene editing systems comprising an rna guide targeting lactate dehydrogenase a (ldha) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1755US2023193243A1Compositions comprising a cas12i2 polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 1854US2024026351A1Compositions comprising an rna guide targeting trac and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 1954US2023059141A1Gene editing systems comprising a nuclease and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 2053US2023407343A1Compositions comprising an rna guide targeting pdcd1 and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2153US2023416732A1Compositions comprising an rna guide targeting bcl11a and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2253US2023235305A1Cells modified by a cas12i polypeptideARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2353US2024174997A1Compositions comprising a variant polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 2453US2023399639A1Compositions comprising an rna guide targeting b2m and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2551US2023332119A1Compositions comprising a cas12i2 variant polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Quinton Norman Wessells files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →